Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN & C3G
  - Search for:
- Neurology
  - BACK
  - Neurology
  - Alzheimer's Disease
  - Epilepsy
  - Insomnia
  - Migraine
  - Multiple Sclerosis
  - Tuberous Sclerosis Complex
  - Search for:
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Conference Calendar
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Oncology

Metastatic Pancreatic Cancer

Advertisment

Stereotactic Body Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer

Metastatic Pancreatic Cancer

Stereotactic Body Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer

patient care perspectives
By Alok Khorana, MD

Modifying Treatment Regimens to Attenuate Toxicity in Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer

Modifying Treatment Regimens to Attenuate Toxicity in Metastatic Pancreatic Cancer

clinical topic updates
By Philip A. Philip, MD, PhD, FRCP

Impact of Newly Approved Treatment Regimens on Practice Patterns in Pancreatic Cancer

Metastatic Pancreatic Cancer

Impact of Newly Approved Treatment Regimens on Practice Patterns in Pancreatic Cancer

clinical study insights
By Thomas A. Abrams, MD

Treatments With Novel Modes of Action Being Studied in Pancreatic Cancer

Metastatic Pancreatic Cancer

Treatments With Novel Modes of Action Being Studied in Pancreatic Cancer

expert roundtables
By Andrew Hendifar, MD, MPH; Thomas A. Abrams, MD

Quality of Life as an Outcome in the Treatment of Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer

Quality of Life as an Outcome in the Treatment of Metastatic Pancreatic Cancer

clinical study insights
By Andrew Hendifar, MD, MPH; Thomas A. Abrams, MD

Load More

Experts in Metastatic Pancreatic Cancer

+3

Meet the Experts

Advertisment

2024 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

By submitting a new user registration you’re agreeing to the Privacy Policy and Terms of Service for Expert Perspectives in Medicine and its subsidiaries.